Alpha 2.0
Login Register
» Articles » PMID: 30395917

Idiopathic Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Prevalence and Patients' Characteristics

Overview
Journal J Am Acad Dermatol
Specialty Dermatology
Date 2018 Nov 6
PMID 30395917
Citations 3
Authors
Guillaume Chaby
Saskia Ingen-Housz-Oro
Nicolas de Prost
Pierre Wolkenstein
Olivier Chosidow
Laurence Fardet
Affiliations
Soon will be listed here.
Citing Articles

Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management.

Shah H, Parisi R, Mukherjee E, Phillips E, Dodiuk-Gad R Am J Clin Dermatol. 2024; 25(6):891-908.

PMID: 39278968 PMC: 11511757. DOI: 10.1007/s40257-024-00889-6.

Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Li D, Velasquez G, Romar G, Schunkert E, Foreman R, Divito S JAMA Dermatol. 2023; 159(8):830-836.

PMID: 37342052 PMC: 10285678. DOI: 10.1001/jamadermatol.2023.1693.

Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Kuijper E, French L, Tensen C, Vermeer M, Bouwes Bavinck J J Eur Acad Dermatol Venereol. 2020; 34(9):1957-1971.

PMID: 32415695 PMC: 7496676. DOI: 10.1111/jdv.16339.